H.C. Wainwright Starts 60 Degrees Pharmaceuticals Inc (SXTP) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts SXTP Hot Sheet
Price: $0.91 --0%
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Rating Summary:
1 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 13 | New: 3
Join SI Premium – FREE
H.C. Wainwright analyst Ed White initiates coverage on 60 Degrees Pharmaceuticals Inc (NASDAQ: SXTP) with a Neutral rating.
For an analyst ratings summary and ratings history on 60 Degrees Pharmaceuticals Inc click here. For more ratings news on 60 Degrees Pharmaceuticals Inc click here.
Shares of 60 Degrees Pharmaceuticals Inc closed at $0.82 yesterday.
You May Also Be Interested In
- Stephens Starts Dropbox (DBX) at Equal Weight, 'Show Us Growth'
- Stifel Resumes Innate Pharma S.A. (IPH:FP) (IPHA) at Buy
- H.C. Wainwright Assumes Autolus Therapeutics plc (AUTL) at Buy
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
